Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Some women taking part in RECOVER research were more likely to experience Long COVID compared to men.
During the November 12th RECOVER Research Review (R3) Seminar, researchers described how they are studying people’s health and habits both before and during the pandemic to answer important questions about COVID-19 and its long-term effects. Specifically, two studies using data collected by the Collaborative Cohort of Cohorts for COVID-19 Research (C4R) have identified several different factors that could impact the protective effects of COVID-19 vaccines.
Researchers can learn how to access and use data from RECOVER’s pediatric observational study during the next BioData Catalyst® (BDC) Community Hours event, scheduled for Tuesday, December 3rd, 2024, at 1:00 pm EST.
On November 21, NIAID and FNIH launched its first in a series of online webinars highlighting recent progress in the new Researching COVID to Enhance Recovery - Treating Long COVID (RECOVER-TLC) program.
Recent findings from across RECOVER’s five research areas could improve our ability to identify people with Long COVID, understand the underlying causes of their symptoms, and provide them with care and treatment.
By reviewing patient medical records from as early as March 2020, the findings from these studies provide insights into potential risks associated with developing Long COVID.
NIH leaders will discuss the current status of RECOVER-TLC, share information about potential Long COVID treatments to be tested in RECOVER-TLC clinical trials, and answer questions from the public.
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.